As of Feb 10
| +3.85 / +5.65%|
The 15 analysts offering 12-month price forecasts for Charles River Laboratories International Inc have a median target of 83.00, with a high estimate of 97.50 and a low estimate of 60.00. The median estimate represents a +15.26% increase from the last price of 72.01.
The current consensus among 21 polled investment analysts is to Hold stock in Charles River Laboratories International Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.